2022
DOI: 10.1021/acs.analchem.2c03437
|View full text |Cite
|
Sign up to set email alerts
|

Rapid Point-of-Care Assay by SERS Detection of SARS-CoV-2 Virus and Its Variants

Abstract: Addressing the spread of coronavirus disease 2019 (COVID-19) has highlighted the need for rapid, accurate, and low-cost diagnostic methods that detect specific antigens for SARS-CoV-2 infection. Tests for COVID-19 are based on reverse transcription PCR (RT-PCR), which requires laboratory services and is time-consuming. Here, by targeting the SARS-CoV-2 spike protein, we present a point-of-care SERS detection platform that specifically detects SARS-CoV-2 antigen in one step by captureing substrates and detectio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 40 publications
0
19
0
Order By: Relevance
“…These results indicate that we can quantitate SARS-CoV-2 in a variety of media at levels similar to or better than most lateral flow or ELISA tests. In addition, a comparison of different biosensors recently published to detect the SARS-CoV-2 virus is listed in Table S2. Our method also has a comparable or better detection limit than some of the listed methods. …”
Section: Resultsmentioning
confidence: 82%
“…These results indicate that we can quantitate SARS-CoV-2 in a variety of media at levels similar to or better than most lateral flow or ELISA tests. In addition, a comparison of different biosensors recently published to detect the SARS-CoV-2 virus is listed in Table S2. Our method also has a comparable or better detection limit than some of the listed methods. …”
Section: Resultsmentioning
confidence: 82%
“…Hence, to obtain accurate statistical results, we used a subtraction method to subtract the number of background impurities by designing control groups (Figure S11). For the coronavirus, we set a gradient from 10 3 to 10 5 TU/mL, meeting most respiratory virus detection requirements, to prove the feasibility of growth at different pseudovirus-SARS-CoV-2 concentrations. , Figure d,e shows the particle size analysis and linear fitting curves of the virus microspheres. The virus microspheres were around 1.5 μm in size, and the total particle number was consistent with the preset concentration.…”
Section: Resultsmentioning
confidence: 99%
“…In order to improve specificity in SERS detection, functionalized probes are usually developed and used to modify the substrate. [61][62][63] Although the affinity screening method based on immobilized proteins has demonstrated dramatic advances in screening bioactive compounds from natural products, [64][65][66] it is still challenged by long screening time, binder loss and low contents in samples. To address the urgent needs, Zhao et al have employed a dual-functional SERS probe to screen and detect bioactive ingredients binding to the target protein from Gardenia jasminoides extract.…”
Section: Bioactive Constituent Detectionmentioning
confidence: 99%